Showing 1-10 of 13 results for "".

• MATV News: Promising Data for Galderma's RelabotulinumtoxinA; FDA Approves Sientra's New Breast Implant; Allergan Aesthetics Shares Global Trends Report

  https://modernaesthetics.com/series/matv-news/matv-news-promising-data-for-galdermas-relabotulinumtoxina-fda-approves-sientras-new-breast-implant-allergan-aesthetics-shares-global-trends-report/33697/
  Galderma's investigational RelabotulinumtoxinA, a novel liquid formulation botulinum toxin A, improves glabellar and lateral canthal lines with a rapid onset of action and a long duration up to six months, according to top-line Phase 3 data; and Sientra wins FDA approval for its Low Plus Profile Pro
  • Video

• It's All Relative: Embracing the Einsteinian Approach To Aesthetics

  https://modernaesthetics.com/ma-issues-index/2019-sept-oct/its-all-relative-embracing-the-einsteinian-approach-to-aesthetics/34814/
  • Text

• Sientra Doubles Down on Commitment to Breast Implant Safety

  https://modernaesthetics.com/ma-issues-index/2022-mar-apr/sientra-doubles-down-on-commitment-to-breast-implant-safety/35141/
  • Text
• New In My Practice: The Viality Fat Transfer System by Sientra with Dr. David Shafer
  https://modernaesthetics.com/news/new-in-my-practice-the-viality-fat-transfer-system-by-sientra-with-david-shafer-md/2473501/
  AestheticsWire recently sat down with New York City plastic surgeon David Shafer, MD to discuss how the use of the Viality Fat Transfer System by Sientra has improved his fat transfer procedures. AestheticsWire: What is the Viality Fat Transfer System by Sientra?<
• Aziyo Biologics, Sientra Partner to Distribute SimpliDerm Products
  https://modernaesthetics.com/news/aziyo-biologics-sientra-partner-to-distribute-simpliderm-product-line/2473379/
   Aziyo Biologics, Inc. and Sientra, Inc. are joining forces to expand the distribution of Aziyo’s SimpliDerm product line.  Under the agreement terms, Aziyo will grant Sientra certain non-exclusive rights in the United States to market, sell, and distribute SimpliDerm fo
• Sientra Announces First Shipment of Viality Fat Transfer System; New Preliminary Data
  https://modernaesthetics.com/news/sientra-launches-viality-fat-transfer-system/2473374/
  Sientra announced that it has begun commercial shipping of its Viality with AuraClens fat transfer system. The company also announced the release of preliminary results from its ongoing, multicenter, long-term volume retention clinical study with Viality. These results show over 80% vol
• Sientra Gives Back: Company Launches Several Breast Cancer Awareness Initiatives
  https://modernaesthetics.com/news/sientra-gives-back-company-launches-several-breast-cancer-awareness-initiatives/2473306/
  Sientra  is launching several initiatives in honor of Breast Cancer Awareness Month.  Sientra has partnered with actress and breast cancer survivor, Miranda McKeon; collaborated with the Brem Foundation to launch “Sientra Supports”; and continues to support Re
• FDA Nod for Sientra’s Low Plus Profile Projection Breast Implant
  https://modernaesthetics.com/news/fda-nod-for-sientras-low-plus-profile-projection-breast-implant-1/2473263/
  The U.S. Food and Drug Administration (FDA) approved Sientra’s Low Plus Profile Projection Breast Implant for breast augmentation in women at least 22 years old, and for women of all ages undergoing breast reconstruction. This product will be commercially available for board-certi
• Sientra’s Allox2 Helps Manage Seroma and Infection in Prepectoral Breast Reconstruction
  https://modernaesthetics.com/news/sientras-allox2s-helps-manage-seroma-and-infection-in-prepectoral-breast-reconstruction/2473138/
  The Sientra Allox2 dual port tissue expander enables efficient management of seroma and early targeted intervention in prepectoral breast reconstruction, according to a new study on PRS Global Open. Seroma are among the most common complications after staged prepectoral implant
• Cynosure Taps Vet Dr. Rafael Sierra for R&D Position
  https://modernaesthetics.com/news/cynosure-taps-vet-rafael-sierra-phd-for-rd-position/2472992/
  Rafael Sierra, PhD is back at Cynosure. The former Chief Technology Officer is now an R&D Advisor.  "Dr. Sierra's passion for the science behind medical aesthetics and inherent knowledge of its clinical application are unparalleled," says Todd

• Prev
• 1
• 2
• Next